Enhertu® (fam-trastuzumab deruxtecan-nxki)
for Lung Cancer

Enhertu (fam-trastuzumab deruxtecan) is a targeted therapy and chemotherapy combination used to treat HER2-positive breast cancer, advanced stomach cancer, non-small cell lung cancer, and solid tumors with HER2 gene mutations. It is an antibody-drug conjugate (ADC) that targets HER2-positive cancer cells. Enhertu works by binding to HER2, slowing cancer growth, and delivering chemotherapy (deruxtecan) directly into the cells to destroy them.

Heart